VIPR2 Protein (AA 24-126) (mFc Tag)
-
- Target See all VIPR2 Proteins
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
- Protein Type
- Recombinant
- Protein Characteristics
- AA 24-126
- Origin
- Human
-
Source
- HEK-293 Cells
- Purification tag / Conjugate
- This VIPR2 protein is labelled with mFc Tag.
- Purpose
- Human VIPR2 Protein
- Sequence
- Glu24-Val126
- Characteristics
- Recombinant Human VIPR2 Protein is expressed from HEK293 with mFc tag at the C-terminus.It contains Glu24-Val126.
- Purity
- > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
- Sterility
- 0.22 μm filtered
- Endotoxin Level
- Less than 1EU per μg by the LAL method.
- Top Product
- Discover our top product VIPR2 Protein
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.
- Buffer
- Lyophilized from 0.22 μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
- Storage
- -20 °C,-80 °C
- Storage Comment
- -20 to -80°C for 12 months as supplied from date of receipt., -80°C for 3-6 months after reconstitution., 2-8°C for 2-7 days after reconstitution., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Expiry Date
- 12 months
-
- Target
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
- Alternative Name
- VIPR2 (VIPR2 Products)
- Synonyms
- C16DUPq36.3 Protein, DUP7q36.3 Protein, PACAP-R-3 Protein, PACAP-R3 Protein, VIP-R-2 Protein, VPAC2 Protein, VPAC2R Protein, VPCAP2R Protein, VIPR2 Protein, LOC100136266 Protein, Vip2 Protein, pacap Protein, vpac2 Protein, vpac2-R Protein, vpac2-r Protein, vpcap2r Protein, LOC100229999 Protein, vasoactive intestinal peptide receptor 2 Protein, vasoactive intestinal polypeptide receptor type 2 Protein, VIPR2 Protein, LOC100136266 Protein, Vipr2 Protein, vipr2 Protein
- Background
- Effects of vasoactive intestinal peptide (VIP) on T cell migration are mediated by structurally distinct types I (VIPR1) and II (VIPR2) G protein-associated receptors. The two receptor types were proposed to transduce opposite effects on human T cells, since cytokine-induced chemotaxis of VIPR1-bearing HuT 78 human T cells, in contrast to T cells that express VIPR2, was inhibited by VIP.
- Molecular Weight
- 37.35 kDa. Due to glycosylation, the protein migrates to 45-60 kDa based on Tris-Bis PAGE result.
- Pathways
- cAMP Metabolic Process
-